Device type · PMP
Dorsal Root Ganglion Stimulator For Pain Relief
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PMP
Neurology
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
1,966
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Dorsal Root Ganglion Stimulator For Pain Relief
- Product code
- PMP
- Device class
- Class III
- Review panel
- Neurology
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for PMP
Latest FDA decisions
P150004 · Decided Feb 11, 2016 · 378 days after receipt
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
Reports received
1,966
Received Nov 1, 2025 to Nov 19, 2026. Includes 6 of another or unstated type.
Malfunction reports
27
1.4% of reports
Injury reports
1,932
98% of reports
Death reports
1
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 158 | 0 | 0 |
| Jan 24 | 3 | 167 | 0 | 0 |
| Feb 24 | 4 | 196 | 0 | 0 |
| Mar 24 | 2 | 197 | 0 | 0 |
| Apr 24 | 1 | 160 | 0 | 0 |
| May 24 | 0 | 179 | 1 | 0 |
| Jun 24 | 1 | 136 | 0 | 0 |
| Jul 24 | 5 | 139 | 0 | 0 |
| Aug 24 | 1 | 181 | 0 | 0 |
| Sep 24 | 1 | 159 | 0 | 0 |
| Oct 24 | 2 | 181 | 0 | 0 |
| Nov 24 | 1 | 159 | 0 | 0 |
| Dec 24 | 0 | 199 | 0 | 0 |
| Jan 25 | 2 | 179 | 0 | 0 |
| Feb 25 | 0 | 194 | 0 | 0 |
| Mar 25 | 6 | 167 | 0 | 0 |
| Apr 25 | 3 | 159 | 0 | 0 |
| May 25 | 2 | 166 | 0 | 0 |
| Jun 25 | 4 | 170 | 0 | 0 |
| Jul 25 | 1 | 178 | 0 | 0 |
| Aug 25 | 0 | 169 | 0 | 0 |
| Sep 25 | 1 | 132 | 0 | 0 |
| Oct 25 | 3 | 162 | 0 | 0 |
| Nov 25 | 3 | 139 | 0 | 0 |
| Dec 25 | 2 | 143 | 0 | 0 |
| Jan 26 | 4 | 166 | 0 | 0 |
| Feb 26 | 1 | 128 | 0 | 0 |
| Mar 26 | 2 | 167 | 0 | 0 |
| Apr 26 | 2 | 165 | 0 | 0 |
| May 26 | 4 | 167 | 0 | 0 |
| Jun 26 | 2 | 178 | 1 | 0 |
| Jul 26 | 0 | 168 | 0 | 1 |
| Aug 26 | 2 | 175 | 0 | 3 |
| Sep 26 | 3 | 184 | 0 | 0 |
| Oct 26 | 2 | 152 | 0 | 2 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Migration549
- High impedance339
- Adverse Event Without Identified Device or Use Problem230
- Therapeutic or Diagnostic Output Failure223
- Fracture219
- Use of Device Problem102
- Insufficient Device Problem Information80
- Wireless Communication Problem55
- Material Fragmentation53
- Impedance Problem44
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Inadequate Pain Relief1,330
- No Clinical Signs, Symptoms or Conditions192
- Implant Pain129
- Insufficient Information71
- Device Embedded In Tissue or Plaque67
- Foreign Body In Patient62
- Undesired Nerve Stimulation45
- Unspecified Infection34
- Post Operative Wound Infection19
- Wound Dehiscence12
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2367-2024 · Started May 16, 2024 · Posted by FDA Jul 16, 2024
Reason given: The duration between the implantable pulse generator reaching the elective replacement indicator threshold and end of service may be shorter than indicated in product labeling.
Cause as FDA categorized it: Vendor change control
Z-1170-2018 · Started Mar 9, 2018 · Posted by FDA Mar 23, 2018
Reason given: The firm received complaints of error messages that occurred during routine impedance checks on Proclaim DRG IPGs, model 3664. Some complaints were also associated with transient over stimulation which created discomfort for the patients.
Cause as FDA categorized it: Software change control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.